Ebola Can Linger in the Brains of Survivors Even After Antibody Treatment, Study Suggests

Share
  • February 9, 2022

New research in animals seems to confirm the frightening resilience of the Ebola virus. The study found that the virus could routinely persist in the brains of monkeys following treatment with monoclonal antibodies, even sometimes resurfacing weeks later to cause acute illness and death. The findings, the authors say,…

Read more…

Source : Ebola Can Linger in the Brains of Survivors Even After Antibody Treatment, Study Suggests